PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-62.12%
Negative revenue growth while ECL.AX stands at 32.82%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-4.76%
Negative gross profit growth while ECL.AX is at 22.07%. Joel Greenblatt would examine cost competitiveness or demand decline.
-133.92%
Negative EBIT growth while ECL.AX is at 38.78%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-133.92%
Negative operating income growth while ECL.AX is at 38.78%. Joel Greenblatt would press for urgent turnaround measures.
-104.47%
Negative net income growth while ECL.AX stands at 45.47%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-100.00%
Negative EPS growth while ECL.AX is at 45.37%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-100.00%
Negative diluted EPS growth while ECL.AX is at 45.55%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-3.68%
Share reduction while ECL.AX is at 0.01%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-7.83%
Reduced diluted shares while ECL.AX is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
49.89%
Positive OCF growth while ECL.AX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
180.79%
Positive FCF growth while ECL.AX is negative. John Neff would see a strong competitive edge in net cash generation.
-12.63%
Negative 10Y revenue/share CAGR while ECL.AX stands at 9.65%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
66.44%
5Y revenue/share CAGR under 50% of ECL.AX's 154.15%. Michael Burry would suspect a significant competitive gap or product weakness.
68.94%
3Y revenue/share CAGR at 75-90% of ECL.AX's 79.01%. Bill Ackman would expect new product strategies to close the gap.
992.35%
Positive long-term OCF/share growth while ECL.AX is negative. John Neff would see a structural advantage in sustained cash generation.
163.21%
5Y OCF/share CAGR 1.25-1.5x ECL.AX's 109.69%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
1886.98%
Positive 3Y OCF/share CAGR while ECL.AX is negative. John Neff might see a big short-term edge in operational efficiency.
-158.18%
Negative 10Y net income/share CAGR while ECL.AX is at 107.27%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-105.95%
Negative 5Y net income/share CAGR while ECL.AX is 327.60%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
69.70%
3Y net income/share CAGR 50-75% of ECL.AX's 136.10%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
164.53%
5Y equity/share CAGR above 1.5x ECL.AX's 40.92%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
90.05%
3Y equity/share CAGR above 1.5x ECL.AX's 25.32%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-63.41%
Firm’s AR is declining while ECL.AX shows 19.72%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-10.39%
Inventory is declining while ECL.AX stands at 24.20%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
9.77%
Similar asset growth to ECL.AX's 10.76%. Walter Schloss finds parallel expansions or investment rates.
2.75%
Under 50% of ECL.AX's 7.02%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-13.80%
We’re deleveraging while ECL.AX stands at 3.71%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-5.29%
We cut SG&A while ECL.AX invests at 6.81%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.